These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 12111580)
21. Significant inhibition of human CD8(+) cytotoxic T lymphocyte-mediated xenocytotoxicity by overexpression of the human decoy Fas antigen. Kawamoto K; Tanemura M; Nishida T; Fukuzawa M; Ito T; Matsuda H Transplantation; 2006 Mar; 81(5):789-96. PubMed ID: 16534484 [TBL] [Abstract][Full Text] [Related]
22. Promotive Effects of Dcr3 Gene on the Occurrence and Progression of Gastric Cancer and its Mechanism. Zheng XF; Miao LY; Li S; Wang YB Hepatogastroenterology; 2014 May; 61(131):880-4. PubMed ID: 26176090 [TBL] [Abstract][Full Text] [Related]
23. Idiopathic pulmonary fibrosis fibroblasts become resistant to Fas ligand-dependent apoptosis via the alteration of decoy receptor 3. Im J; Kim K; Hergert P; Nho RS J Pathol; 2016 Sep; 240(1):25-37. PubMed ID: 27218286 [TBL] [Abstract][Full Text] [Related]
24. Ascites from epithelial ovarian cancer contain high levels of functional decoy receptor 3 (DcR3) and is associated with platinum resistance. Connor JP; Felder M Gynecol Oncol; 2008 Nov; 111(2):330-5. PubMed ID: 18723214 [TBL] [Abstract][Full Text] [Related]
25. Over-expression of decoy receptor 3 in gastric precancerous lesions and carcinoma. Chen G; Luo D Ups J Med Sci; 2008; 113(3):297-304. PubMed ID: 18991242 [TBL] [Abstract][Full Text] [Related]
26. Decoy receptor 3 is a prognostic factor in renal cell cancer. Macher-Goeppinger S; Aulmann S; Wagener N; Funke B; Tagscherer KE; Haferkamp A; Hohenfellner M; Kim S; Autschbach F; Schirmacher P; Roth W Neoplasia; 2008 Oct; 10(10):1049-56. PubMed ID: 18813347 [TBL] [Abstract][Full Text] [Related]
27. Correlation between expression of DcR3 on tumor cells and sensitivity to FasL. Li W; Zhang C; Chen C; Zhuang G Cell Mol Immunol; 2007 Dec; 4(6):455-60. PubMed ID: 18163957 [TBL] [Abstract][Full Text] [Related]
28. Increased expression of soluble decoy receptor 3 in acutely inflamed intestinal epithelia. Kim S; Fotiadu A; Kotoula V Clin Immunol; 2005 Jun; 115(3):286-94. PubMed ID: 15893696 [TBL] [Abstract][Full Text] [Related]
29. Decoy receptor 3 regulates the expression of various genes in rheumatoid arthritis synovial fibroblasts. Fukuda K; Miura Y; Maeda T; Takahashi M; Hayashi S; Kurosaka M Int J Mol Med; 2013 Oct; 32(4):910-6. PubMed ID: 23912906 [TBL] [Abstract][Full Text] [Related]
30. Decoy receptor 3: a pleiotropic immunomodulator and biomarker for inflammatory diseases, autoimmune diseases and cancer. Lin WW; Hsieh SL Biochem Pharmacol; 2011 Apr; 81(7):838-47. PubMed ID: 21295012 [TBL] [Abstract][Full Text] [Related]
31. Expression of a soluble decoy receptor 3 in patients with diffuse large B-cell lymphoma predicts clinical outcome. Chang PM; Chen PM; Hsieh SL; Tzeng CH; Liu JH; Chiou TJ; Wang WS; Yen CC; Gau JP; Yang MH Int J Oncol; 2008 Sep; 33(3):549-54. PubMed ID: 18695885 [TBL] [Abstract][Full Text] [Related]
32. Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status. Michael-Robinson JM; Pandeya N; Cummings MC; Walsh MD; Young JP; Leggett BA; Purdie DM; Jass JR; Radford-Smith GL J Pathol; 2003 Sep; 201(1):46-54. PubMed ID: 12950016 [TBL] [Abstract][Full Text] [Related]
33. Blockade of the Fas/FasL system improves pneumococcal clearance from the lungs without preventing dissemination of bacteria to the spleen. Matute-Bello G; Liles WC; Frevert CW; Dhanireddy S; Ballman K; Wong V; Green RR; Song HY; Witcher DR; Jakubowski JA; Martin TR J Infect Dis; 2005 Feb; 191(4):596-606. PubMed ID: 15655784 [TBL] [Abstract][Full Text] [Related]
34. Crystal Structure of the Complex of Human FasL and Its Decoy Receptor DcR3. Liu W; Ramagopal U; Cheng H; Bonanno JB; Toro R; Bhosle R; Zhan C; Almo SC Structure; 2016 Nov; 24(11):2016-2023. PubMed ID: 27806260 [TBL] [Abstract][Full Text] [Related]
35. Combined treatment with denbinobin and Fas ligand has a synergistic cytotoxic effect in human pancreatic adenocarcinoma BxPC-3 cells. Yang CR; Guh JH; Teng CM; Chen CC; Chen PH Br J Pharmacol; 2009 Aug; 157(7):1175-85. PubMed ID: 19466993 [TBL] [Abstract][Full Text] [Related]
37. Fas-mediated apoptosis and expression of related genes in human malignant hematopoietic cells. Kim KM; Lee K; Hong YS; Park HY Exp Mol Med; 2000 Dec; 32(4):246-54. PubMed ID: 11190279 [TBL] [Abstract][Full Text] [Related]
38. Overexpression of M68/DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Bai C; Connolly B; Metzker ML; Hilliard CA; Liu X; Sandig V; Soderman A; Galloway SM; Liu Q; Austin CP; Caskey CT Proc Natl Acad Sci U S A; 2000 Feb; 97(3):1230-5. PubMed ID: 10655513 [TBL] [Abstract][Full Text] [Related]
39. Expression of Fas ligand by human gastric adenocarcinomas: a potential mechanism of immune escape in stomach cancer. Bennett MW; O'connell J; O'sullivan GC; Roche D; Brady C; Kelly J; Collins JK; Shanahan F Gut; 1999 Feb; 44(2):156-62. PubMed ID: 9895372 [TBL] [Abstract][Full Text] [Related]
40. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas. Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]